Compare BGS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | OCGN |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.5M | 387.3M |
| IPO Year | 2004 | 2014 |
| Metric | BGS | OCGN |
|---|---|---|
| Price | $5.39 | $1.86 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $4.38 | ★ $7.00 |
| AVG Volume (30 Days) | 2.1M | ★ 3.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 14.34% | N/A |
| EPS Growth | N/A | ★ 31.58 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,932,454,000.00 | N/A |
| Revenue This Year | N/A | $35.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.67 | $0.52 |
| 52 Week High | $8.06 | $1.96 |
| Indicator | BGS | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 68.65 | 70.93 |
| Support Level | $3.99 | $1.48 |
| Resistance Level | N/A | $1.93 |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 81.51 | 86.51 |
B&G Foods Inc is an American packaged-food manufacturer. It operate in a single industry segment and manufacture, sell and distribute a diverse portfolio of high-quality shelf-stable and frozen foods across the United States, Canada and Puerto Rico. Its products include frozen and canned vegetables, vegetable, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, The company's main brands are Ac'cent, B&G, B&M, Baker's Joy, Bear Creek Country Kitchens, Cary's, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril's, Grandma's Molasses, MacDonald's.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").